| Registry | NCT07725926, acronym TORCH |
|---|---|
| Status | Recruiting |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: single, treatment |
| Enrollment | 40 (Estimated) |
| Sponsor | University College London Hospitals (Other); collaborators: University College, London |
| Conditions | Obsessive - Compulsive Disorder, Tic Disorder, Chronic Motor or Vocal, Tic Disorders, Tic Disorder, Combined Vocal and Multiple Motor, Tourette Disease, Tourette Disorder, Tourettes Syndrome, Gilles de la Tourette Syndrome |
| Interventions | Exposure and Response Prevention (ERP), Habit Reversal Training (HbRT, Psychoeducation and Supportive Intervention (Behavioral) |
| Dates | start 2026-07-08, primary completion 2027-08-01 (estimated), completion 2030-02-01 (estimated), first posted 2026-07-24, last updated 2026-07-27 |
| Locations | 2 sites in United Kingdom |
Related Papers Related Patents Related Grants Related Experts
All trials for Obsessive - Compulsive Disorder All trials for Tic Disorder, Chronic Motor or Vocal All trials of Exposure and Response Prevention (ERP) All trials of Habit Reversal Training (HbRT
Obsessive-Compulsive Disorder and Tic Disorders frequently co-occur, and a subgroup of patients - those with a Tourettic Subtype of OCD (TOCD) - present with concurrent obsessive-compulsive and tic symptoms. Existing psychological interventions typically target one condition or the other, but rarely both together. This study aims to test whether a combined psychological therapy integrating Exposure and Response Prevention (ERP) and Habit Reversal (HbRT) is more effective at reducing symptoms than either therapy delivered alone, in adults with TOCD.
Participants are randomly allocated to one of four groups: (1) combined ERP and HbRT, (2) ERP alone, (3) HbRT alone, or (4) a supportive psychoeducation control. All participants receive 12 weekly one-to-one sessions (either in-person or remotely) of approximately fifty minutes. Symptoms will be assessed using the Yale Global Tic Severity Scale (YGTSS) and Yale-Brown Obsessive Compulsive Scale (Y-BOCS) by an independent clinician at the start of treatment, at Week 12, and again at Week 24.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Combined Exposure and Response Prevention and Habit Reversal | Experimental | Behavioral: Exposure and Response Prevention (ERP); Behavioral: Habit Reversal Training (HbRT | Participants allocated to this arm will receive a 12-week individual psychological intervention integrating Exposure and Response Prevention (ERP) and Habit Reversal Training (HRT). ERP will involve planned exposure to obsessional fears, distress, sensory discomfort, premonitory urges, and "not-just-right" experiences while reducing compulsions, avoidance, reassurance seeking, and other safety behaviours. HRT will include awareness training, identification of premonitory urges and tic-related cues, development and practice of competing responses, and strategies to support generalisation. Sessions will last approximately 50 minutes and will be delivered face-to-face or remotely. |
| Standardised Exposure and Response Prevention | Active comparator | Behavioral: Exposure and Response Prevention (ERP) | Participants allocated to this arm will receive a 12-week individual psychological intervention based on Exposure and Response Prevention (ERP). Treatment will involve gradual and systematic exposure to obsessional fears, distress, sensory discomfort, premonitory urges, and "not-just-right" experiences while refraining from compulsions, avoidance, reassurance seeking, and other safety behaviours. The intervention aims to reduce obsessive-compulsive symptoms by promoting inhibitory learning and increasing tolerance of uncertainty and internal experiences. Sessions will last approximately 50 minutes and will be delivered face-to-face or remotely. |
| Standardised Habit Reversal | Active comparator | Behavioral: Habit Reversal Training (HbRT | Participants allocated to this arm will receive a 12-week individual psychological intervention based on Habit Reversal Training (HbRT). Treatment will include awareness training to improve recognition of tics and premonitory urges, identification of antecedents and contextual triggers, development and practice of competing responses, and strategies to promote generalisation of skills to everyday settings. The intervention aims to reduce tic severity and improve voluntary tic management. Sessions will last approximately 50 minutes and will be delivered face-to-face or remotely. |
| Psychoeducation / Supportive Intervention | Active comparator | Behavioral: Psychoeducation and Supportive Intervention | Participants allocated to this arm will receive a 12-week individual psychological intervention consisting of psychoeducation and supportive therapy. Sessions will provide information about obsessive-compulsive disorder, tic disorders, Tourettic obsessive-compulsive disorder, stress, and wellbeing, together with supportive discussion and general problem-solving. This intervention will not include structured Exposure and Response Prevention, Habit Reversal Training, or other targeted behavioural techniques. Sessions will last approximately 50 minutes and will be delivered face-to-face or remotely. |
Sex: All, ages: 18 Years to 65 Years
Inclusion Criteria: 1. Age 18 years or older 2. All genders 3. Confirmation of a primary diagnosis of either: a. Tourettes Disorder / Tourette Syndrome b. Persistent Motor or Vocal Tic Disorder / Chronic Motor or Vocal Tic Disorder c. Provisional Tic Disorder / Transient Motor Tics d. Other Specified Tic Disorder e. Unspecified Tic Disorder f. Obsessive-Compulsive Disorder \[d\] Participants taking psychotropic medication are eligible provided medication type and dose remain stable throughout the intervention period \[e\] Ability to provide sustained informed consent \[f\] A minimum score of 16 on YBOCS \[g\] A minimum score of 5 on the Premonitory Urge for Tics Scale (PUTS) Exclusion Criteria: 1. Substance misuse 2. Current diagnosis of a personality disorder 3. Schizophrenia 4. Bipolar disorder 5. Contraindications to participation in a trial (i.e., active suicidal ideations and/or requirement of an interpreter) 6. Any psychiatric or neurological condition that, in the opinion of the investigators, would interfere with participation or interpretation of study outcomes.
| Facility | City | Country | Status |
|---|---|---|---|
| University College London Hospitals NHS Foundation Trust | London, London | United Kingdom | Recruiting |
| University College London Queen Square Institute of Neurology | London, London | United Kingdom | Recruiting |